Ad
AKRX Stock - Akorn Stock Trading
About | Akorn Inc. (NASDAQ:AKRX)
Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and prescription pharmaceuticals. The firm has two segments namely Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals including sterile ophthalmics, injectables, and inhalants, and non-sterile oral liquids, topicals and nasal sprays whereas the Consumer Health segment consist of animal health and over-the-counter products, both branded and private-label. The company generates a majority of its revenue from the Prescription Pharmaceuticals segment.
Quote | Akorn Inc. (NASDAQ:AKRX)
| Last: | $0.09 |
|---|---|
| Change Percent: | -51.01% |
| Open: | $0.18 |
| Close: | $0.09 |
| High: | $0.195 |
| Low: | $0.09 |
| Volume: | 33,469,001 |
| Last Trade Date Time: | 05/29/2020 04:56:18 pm |
News | Akorn Inc. (NASDAQ:AKRX)
-
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg PR Newswire GURNEE, Ill. , Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic v...
Message Board Posts | Akorn Inc. (NASDAQ:AKRX)
| Subject | By | Source | When |
|---|---|---|---|
| Thanks for the dd Tduggylolz! | leonardo66 | investorshub | 10/25/2020 11:19:19 PM |
| AKRXQ: Bankruptcy PLAN effective. All shares cancelled. | Renee | investorshub | 10/02/2020 3:28:04 PM |
| $AKRXQ stock is completely worthless. When Lenders take | Ronin | investorshub | 09/21/2020 2:11:33 PM |
| It looks like some (bad) news hit today | contrarian bull | investorshub | 09/11/2020 6:03:30 PM |
| This is a weird play now don't | Long isle T | investorshub | 09/08/2020 8:50:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg PR Newswire GURNEE, Ill. , Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic v...